secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0001193125-23-048745
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics adds 500,000 shares to inducement equity plan for new hires
-------------------------------------------------------------------------------

- Board amended 2020 Inducement Plan to increase share reserve by 500,000 shares.
- Amendment adopted without stockholder approval under Nasdaq Rule 5635(c)(4).
- Plan used for equity awards as material inducement for new employees not previously employed.
- Total shares authorized under plan now 2,000,000 (original 1,500,000 + 500,000).
- Awards may include options, RSUs, restricted stock, SARs, performance shares/units.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312523048745/0001193125-23-048745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312523048745/d420661d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-048745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer